Site icon AIT365

Claimable Launches AI Appeals Platform for Healthcare

Claimable

Claimable, a pioneering healthcare technology company, announced the launch of its AI-powered appeals platform designed to combat unjust healthcare denials. The platform leverages purpose-built AI to analyze clinical research, policy details, appeals data, and patients’ unique medical stories, generating and submitting customized appeals in minutes.

“At Claimable, we’re harnessing the power of AI to give patients a voice in a system that too often drowns them out,” said Warris Bokhari, MD, CEO and Co-Founder of Claimable. “Our mission is to level the playing field, ensuring every patient can reclaim control over their healthcare and get the treatment they’re owed.”

The results from Claimable’s pilot program far exceed industry standards:

Also Read: Mediwhale Raises $12M for Cardiovascular Solutions

“The healthcare system in this country is fundamentally broken, with millions of patients denied the care they need due to profit-driven practices,” said Wendell Potter, Claimable advisor, health insurance reform expert and former insurance executive. “Claimable offers a critical remedy. This platform is a lifeline for those caught in the machinery of an industry that too often prioritizes dollars over lives.”

The platform’s guided appeal builder offers smart document scanning, a dynamic health questionnaire, and instant evidence matching. Unlike static form-based tools, Claimable delivers a personalized experience that adapts to responses in real-time. Each appeal generated features a compelling, fact-based narrative, tailored to the patient’s unique circumstances and story.

Claimable is now available nationwide and accepts denials from all insurance providers, including Medicare, Medicaid, United Healthcare, Anthem, Aetna, Cigna, and BCBS plans. Claimable submits appeals via Fax and First Class Mail, requesting urgent 72-hour reviews when appropriate. With affordability at its core, Claimable charges a fee of $39.95 per appeal, plus shipping.

SOURCE: GlobeNewswire

Exit mobile version